Less protein means more muscle loss unless youre paying attention
The STEP-4 trial of semaglutide showed roughly two-thirds of lost weight returning within a year of discontinuation
It also increases brain levels of glutathione, shielding it against oxidative stress and amyloid beta plaques that destroy neurons in Alzheimers disease [37, 10]
When you combine clinical screening (cardiovascular, renal, thyroid status) with genetic insights into GLP-1 pathways, you gain a more comprehensive picture
Key takeaways Retatrutide isn't approved yet and isn't expected to launch in the UK until at least mid-2026 In clinical trials, target doses ranged from 0.5mg to 12mg weekly, with the most common being 4mg, 8mg, 9mg and 12mg Different dosing schedules were tested, with most people starting at 2mg and escalating every 4 weeks The 12mg dose produced the most weight loss (up to 28.7% after 68 weeks) Starting at 2mg rather than 4mg helped reduce side effects during escalation First to know Get an email the day retatrutide launches in the UK
